Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study

Completed · Phase 4

Conditions studied: Arrhythmia

In brief

The purpose of this study is to determine if patients implanted with a St. Jude Medical (SJM) implantable cardioverter defibrillator (ICD) will benefit by using AutoIntrinsic Conduction Search (AICS) rather than only a programmed AV/PV delay. This study will compare the two methods of programming with respect to intrinsic activity.

Key facts

Study ID

NCT00187239

Run by

Abbott Medical Devices

People needed

157

Starts

2005-07-01

Expected to finish

2007-08-01

Last updated by the study team

2019-02-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has been implanted with a dual chamber SJM ICD with AICS for 1 month (± 2 weeks).
• At the time of enrollment, patient is paced in the right ventricle (RV) ≤25% of the time as determined by the device diagnostics.
• Patient is medically stable.

You may not qualify if…

• Patient has evidence of atrioventricular (AV) block (first, second or third degree) such that ventricular pacing would be required as part of the patient's routine management
• Patient is unable to comply with the follow-up visits due to geographical, psychological, or any other reasons.
• Patient is younger than 18 years of age.
• Patient is pregnant.

Where it is running

• AtlantiCare Regional Medical Center — Pomona, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.